Diabetes’ JDRF Tries Shock Ad To Push The FDA

Diabetes’ JDRF Tries Shock Ad to Push the FDA

Diabetes’ JDRF Tries Shock Ad to Push the FDA

This is not a story about statistics, yet I have to start there. It is not a story about a shocking ad that ran in the New York Times and Washington Post, yet the uproar started there.
This is the story of how approximately 150,000 people with type 1 diabetes will die, and one among them, a vibrant, healthy and lovely 17-year-old girl who did die, due to a side effect of insulin.
Insulin, which many think is a cure for type 1 diabetes, is not a cure but a medicine that lowers blood sugar. Sometimes so much, that you die. Did you know that?
This ad ran on Nov. 2 and touched off seismic aftershocks among diabetes bloggers and online advocates.
Most who read the ad were stunned. Parents who have a child with diabetes were terrified or angered. The emotional-hit prompted many to question such an unbelievable figure: 1 in 20 people (an estimated 2-4 percent and 6 percent in patients younger than 40 years old) will perish from severe hypoglycemia.
Of the estimated 3 million people in the U.S. with type 1 diabetes, that’s approximately 150,000 people. That’s like wiping out Chattanooga, Tenn. or Rockford, Ill. — wiping them right off the map.
Aaron Kowalski, Juvenile Diabetes Research Foundation (JDRF) vice president, who’s been in charge of hypoglycemia research funding and helped launch, and still oversees, the Artificial Pancreas Project immediately responded to the uproar online.
He said JDRF ran the ad because they want the FDA to understand that tools and technologies, such as artificial pancreas technologies, exist to minimize dangerous low blood sugar; that researc Continue reading

Rate this article
Total 1 ratings
NHS to give free Fitbits and one-to-one weight loss coaching to thousands of obese Brits in bid to slash diabetes

NHS to give free Fitbits and one-to-one weight loss coaching to thousands of obese Brits in bid to slash diabetes

THOUSANDS of tubby Brits will be given free fitness trackers and one-to-one weight loss coaching on the NHS at a cost of £1.2million.
Health chiefs hope the pilot project will help 5,000 at risk of type 2 diabetes keep the disease at bay.
Getty Images - Getty
Patients will be given a mix of wristbands, phone apps, weighing scales, and podcasts and be monitored for up to a year.
The gadgets will work with nutrition and health advice, stress counselling, and personal coaching sessions. The exact combination an individual receives depends on which of five schemes they are enrolled on.
The wristbands will monitor exercise, sleep quality and eating frequency, while the apps will deliver motivational messages and track users’ progress. Support staff will deliver most sessions via phone or video calls.
NHS England, Public Health England and Diabetes UK will launch the project in eight areas this month.
Getty - Contributor
Interventions that prove most successful could be rolled out nationwide. Simon Stevens, of NHS England, said “This is the latest example of the NHS getting practical and serious about new ways to support people staying healthy.”
Diabetes can lead to amputations or early death and accounts for ten per cent of NHS spending. Type 2 diabetes is linked to being overweight and is largely preventable.
Kid friendly TV ads for sugary cereals blamed for child obesity crisis Continue reading

Good Food List for Diabetes

Good Food List for Diabetes

The American Diabetes Association published extensive dietary recommendations for adults with diabetes in the November 2013 issue of “Diabetes Care.” In this report, the association does not recommend any 1 specific diet that all people with diabetes should follow. Instead, the ADA provides a framework for healthy eating that can be tailored to personal preferences and individual needs. Generally, the ADA recommends a diet composed mostly of nutrient-dense whole foods. This means eating natural, unprocessed foods whenever possible and avoiding fast food. Aim to eat a variety of nutritious foods, including nonstarchy vegetables, lean meats, low-fat dairy products and healthy fats and oils.
Video of the Day
The ADA recommends that you fill half your plate with nonstarchy vegetables. Such vegetables are nutrient powerhouses but low in calories and carbohydrates, so filling up on veggies can help with portion control. The list of nonstarchy vegetables includes leafy greens such as spinach, kale, collards, turnips, mustard and lettuce. Broccoli, cauliflower and brussels sprouts are perfect for roasting or steaming. Celery, carrots, radishes and bell pepper strips make good snacks and salad toppers. Mushrooms, onions and garlic are easily added to soups, stews and omelets. So put vegetables on the shopping list and load up on your favorites.
Lean Meats and Fatty Fish
Protein is an important part of a healthy diet. In people with type 2 diabetes, protein may improve the body's ability to respond to insulin. Good sources of protein include chicken, turkey, lean cuts of beef and Continue reading

Type 2 diabetes: Study explains link to sleep hormone melatonin

Type 2 diabetes: Study explains link to sleep hormone melatonin

Researchers have discovered that increasing levels of the sleep hormone melatonin reduces the ability of insulin-producing cells to release insulin. Also, they found the effect is stronger in people who carry a particular gene variant that is linked to higher risk for type 2 diabetes.
The study, led by Lund University in Sweden, is published in the journal Cell Metabolism.
The findings mark the culmination of work that goes back to 2009, when Lund researchers showed that a variant of the gene that codes for the protein known as melatonin receptor 1B (MTNR1B) increases the risk for type 2 diabetes.
Melatonin is a hormone that helps to maintain our day-night cycle, or circadian rhythm, by regulating other hormones. The amount of melatonin in our blood varies through the day. It is affected by light and peaks during the darkest time, at night.
Insulin is a hormone that regulates blood sugar levels. It is produced and released by the beta cells of the pancreas, in response to spikes in blood sugar, such as during digestion.
In type 2 diabetes, which accounts for nearly 90 percent of diabetes, the body either does not produce enough insulin, or cells become less effective at responding to it, which increases demand on the beta cells to produce more. Both of these result in increased levels of blood sugar, which eventually causes serious damage to organs.
In the new study, the researchers worked with lab-cultured beta cells and mice to show that insulin-producing cells respond to increased levels of melatonin by reducing the amount of insulin they release. These signals are conve Continue reading

Dietary Interventions for Type 2 Diabetes: How Millet Comes to Help

Dietary Interventions for Type 2 Diabetes: How Millet Comes to Help

Go to:
Type 2 Diabetes Overview and Associated Complications
Diabetes is a chronic disease that is characterized by high level of blood glucose also known as hyperglycaemia. According to WHO 2015 published figure1, 9% of the world population aged 18 and above has contracted diabetes and an estimated 1.5 million deaths per year are attributed to diabetes directly. It is well known that glucose level of a diabetic patient increases dramatically beyond the normal range after a meal. It is also true that their blood glucose level would soon drop as the body failed to store the excess glucose for later use.
Diabetes is classified into Types 1 and 2. Type 1 diabetes is also known as juvenile diabetes or insulin-dependent diabetes as the patients’ pancreas cannot produce or produces little insulin and often presents itself from childhood (Diabetes.co.uk, 2016c). Type 2 diabetes (T2D), however, often first appears in adults when the body becomes resistant to insulin or fails to make sufficient amounts of insulin (Martin et al., 1992; Weyer et al., 2001). T2D comprises 90% of people with diabetes around the world (NHS choice, 2014). This can largely be the result of excess body weight and physical inactivity. Added complication to T2D is that it presents less marked symptoms than Type 1 diabetes and is often diagnosed only when complications have already arisen.
Major complications caused by hyperglycaemia include atherosclerosis that hardens and narrows the blood vessels. Other diabetes-related complications are heart disease, stroke, retinopathy, and kidney failure (Bitzur et al Continue reading

No more pages to load

Popular Articles

  • Doctors debate danger of popular diabetes drug after FDA amputation warning

    Many San Diego doctors are taking their patients off of Invokana, a widely used diabetes drug, after a large industry-sponsored trial found it doubled the risk of lower limb amputations compared with those taking a placebo. With 23.1 million people in the U.S. diagnosed with diabetes, many of them are taking newer drugs to control glucose. But new research involving one of those drugs, Invokana, s ...

  • FDA approves Medtronic's 'artificial pancreas' for diabetes

    Medtronic Plc won U.S. approval on Wednesday for an "artificial pancreas" that is the first device to automatically deliver the right dose of insulin to patients with type 1 diabetes, freeing them from continually monitoring insulin levels throughout each day. The U.S. Food and Drug Administration, in its approval of the device, the MiniMed 670G, hailed it as a breakthrough. The device offers type ...

  • FDA Approves The First Automated Insulin System For Type 1 Diabetes

    The Food and Drug Administration's approval of a new insulin delivery system for people with Type 1 diabetes is a big deal. With Type 1 diabetes, the pancreas makes little or no insulin so people have to replace it with either multiple daily injections or a pump. In either case, that process involves constant error-prone adjustments, particularly around food and exercise. Over the long term, high ...

  • FDA approves mid-stage trial of vaccine to reverse type 1 diabetes

    Diabetes researchers are hoping that an almost century-old vaccine for preventing tuberculosis may also reverse type 1 diabetes. The FDA has approved a mid-stage trial to test the vaccine, called bacillus Calmette-Guerin (BCG), in 150 adults with advanced cases of the disease. The approval was announced Sunday at the 75th Scientific Sessions of the American Diabetes Association by Dr. Denise Faust ...

  • FDA approves first "artificial pancreas" for type 1 diabetes

    The U.S. Food and Drug Administration on Wednesday approved the first automated insulin delivery system -- a so-called “artificial pancreas” -- for people with type 1 diabetes. “This first-of-its-kind technology can provide people with type 1 diabetes greater freedom to live their lives without having to consistently and manually monitor baseline glucose levels and administer insulin,” Dr. ...

  • FDA approves 'artificial pancreas' to manage diabetes

    (Medtronic) Federal regulators have approved a first-of-a-kind "artificial pancreas," a device that can help some diabetes patients manage their disease by constantly monitoring their blood sugar and delivering insulin as needed. The device from Medtronic was approved Wednesday for patients with Type 1 diabetes, the kind usually diagnosed during childhood. About 5 percent of the nation's 29 millio ...

  • FDA approves Novo Nordisk diabetes drug Ozempic

    (Reuters) - The U.S. Food and Drug Administration on Tuesday approved Novo Nordisk A/S’s diabetes drug Ozempic, setting the stage for a heated battle with Eli Lilly & Co’s Trulicity. Ozempic, known generically as semaglutide, will compete with others in a class known as glucagon-like peptide-1 (GLP-1) analogs, which imitate an intestinal hormone that stimulates the production of insulin. Ozemp ...

  • FDA approves first ‘artificial pancreas’ for diabetes treatment

    The Food and Drug Administration on Wednesday approved the first so-called artificial pancreas, an out-of-body device expected to lift the burden for some diabetics on the daily grind they must go through to keep their blood sugar levels stable. It will be available next spring for patients with type 1 diabetes who are over age 14. The device, which looks like a smartphone, is designed to automati ...

  • FDA Approves First ‘Artificial Pancreas’ for Type 1 Diabetes

    The device — Medtronic’s MiniMed 670G — is what’s known as a hybrid closed-loop system. That means it monitors blood sugar and then delivers necessary background (also known as basal) insulin doses. The device will also shut off when blood sugar levels drop too low. ...

Related Articles